1.
Aziz Nazha, Carlos G. Romo, Hagop Kantarjian, Jorge Cortes. The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia. haematol [Internet]. 2013Oct.3 [cited 2024Jun.13];98(10):e131-e131. Available from: https://haematologica.org/article/view/6821